Diabetes mellitus

Diabetes mellitus is an important health problem with a rapidly increasing incidence in the world. It is considered the epidemic of the century due to its high mortality and morbidity rates and increased socioeconomic burden. In addition, diabetes is a chronic disease that affects all aspects of the lives of individuals and their families and reduces the quality of life with both acute and chronic complications that require compulsory lifestyle changes. Individuals with diabetes need expert help in diabetes management throughout their lives. Providing glycemic control by encouraging the self-management of the diabetic individual with the "holistic care and interdisciplinary team approach" in achieving success in diabetes management constitutes the main goal. The role of the specialist health team and especially the nurses in the team in the fight against diabetes is very valuable. The effect of diabetes nurses has become increasingly important in preventing or delaying diabetes, in recognizing individuals at high risk in the early period, and in protecting diagnosed diabetics from chronic complications and maintaining their quality of life. © 2023 by Nova Science Publishers, Inc. All rights reserved

Psychometric Evaluation of a Turkish Version of the Diabetes Fear of Self-injecting and Self-testing Questionnaire (D-FISQ)

Purpose: To examine the psychometric properties of a Turkish version of the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ)

Intravitreal injections during the COVID-19 pandemic era

Background: This study aimed to evaluate the clinical characteristics and changes in the number of patients receiving intravitreal injections (IVIs) at a tertiary hospital during the coronavirus disease 2019 (COVID-19) pandemic as compared to the pre-pandemic period. Methods: This retrospective, cross-sectional study included 3,211 patients with retinal disease, who received IVIs of anti-vascular endothelial growth factor (anti-VEGF) between January and May 2020. This 5-month period was divided into a pre-pandemic and a pandemic period. Clinical and demographic data were collected and were compared between the patients in each period. All COVID-19 infection precautions were implemented to minimize the potential transmission of COVID-19 to both healthcare workers and patients. Results: A total of 3,211 IVIs were administered to patients with diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and other retinal conditions. Diabetic retinopathy was the most common indication for treatment in the pre-pandemic as well as pandemic periods. Bevacizumab (Avastin, Roche) was the most common IVI type, followed by aflibercept (Eylea, Bayer). Of 3,211 IVIs, 2,943 (91.7%) were administered during the pre-pandemic period and 268 (8.3%) during the pandemic period. There was a statistically significant decrease in injections between the pre-pandemic and pandemic periods, with an overall reduction of 90.8% in IVIs (P < 0.05). No cases of confirmed transmission of COVID-19 orcomplications associated with IVIs were recorded. Conclusions: This study showed that the number of IVIs and patient visits decreased significantly, by more than 10-fold, during the lockdown period. These findings show that COVID-19 has turned the management of sight-threatening eye diseases into a challenging process and must be addressed if future healthcarerestrictions are imposed

Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?

ObjectiveWe had the impression that randomized clinical trials (RCTs) frequently over enrolled patients. Thus, we surveyed power calculations in publications of RCTs of biologics in rheumatoid arthritis (RA) to assess over enrollment

Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review

Aim

Sexual Dysfunction and Sexual Quality of Life in Women with Diabetes: The Study Based on a Diabetic Center

This study was conducted on a cross-sectional basis for the purpose of determining the prevalence of sexual dysfunction (SD) and sexual quality of life in women with diabetes and, showing the correlation of them with some variables associated with diabetes. The study recruited 423 women with diabetes, through a diabetic center for control from January to December 2012. The data was collected with Socio-demographic and Disease Associated Properties Form, Women Sexual Function Index (FSFI) and Sexual Quality of Life Questionnaire-Women (SQLQ). The mean age of the women, who participated in the study, was 50.0 (SD = 11.3) and, their mean marital period was 30.0 (SD = 11.8). 83 % of the women had type 2 and, 17 % of them had type 1 diabetes and, their mean duration of disease is 11.4 (SD = 7.2). 60.5 % of the women expressed that their sexual desire decreased and, 61.7 % of them expressed that their frequency of sexual intercourse reduced after the diagnosis of their disease. According to the total FSFI scores, 80.4 % of the women had SD. The frequency of SD in women with type 2 diabetes (85.6 %) was significantly higher than that in women with type 1 diabetes (%55.6) (p < 0.001). The sexual quality of life of women with SD (62.7 +/- A 21.2) was significantly lower than that of those without SD (89.6 +/- A 9.9) (p < 0.001). According to these study results, SD was prevalent in women with diabetes, particularly those with type 2 diabetes and also their sexual quality of life was low in parallel with this

Psychosocial Adjustment to Illness and Methods of Coping with Stress Among Young Adults with Type 1 Diabetes

Aim: The present study was performed to evaluate the psychosocial adjustment to illness and methods of coping with stress among young adults with type 1 diabetes